Health perspectives among Halabja's civilian survivors of sulfur mustard exposure with respiratory symptoms-A qualitative study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
17
06
2018
accepted:
06
06
2019
entrez:
22
6
2019
pubmed:
22
6
2019
medline:
11
2
2020
Statut:
epublish
Résumé
In 1988, Halabja came under heavy chemical warfare attack using chemicals such as sulfur mustard (SM). Thousands of survivors of SM exposure in the city today live with multiple health complaints, such as severe, long-lasting respiratory symptoms; but their perceptions of health have never been adequately researched. We aimed to explore current major health concern topics in civilian survivors with long-term respiratory symptoms. Sixteen subjects (f:m10:6, mean age 45.5 years (range 34-67)) were interviewed. Study participants were recruited in 2016 via a purposive sampling strategy among civilian survivors of chemical warfare in the city of Halabja in Kurdistan-Iraq. A qualitative research design was applied including semi-structured, face-to-face interviews. Data was analyzed using systematic text condensation. The analysis yielded fourteen themes related to: (1) General health: all participants described a deterioration in physical and psychological health, following the SM exposure, foremost involving respiratory symptoms, fatigue, sleeping disorders, ocular problems, depressive symptoms, and anxiety; (2) Quality of life: most notably, they reported a limited family life, limited social relations, lack of work ability, and concern about their financial situation. Moreover, many lived in constant fear of a renewed attack; (3) access to health care services: all participants reported that they had no, or only poor, access to health care services and limited access to specialist care, and all reported lack of financial resources to obtain treatment. The post-exposure somatic and psychosocial effects such as respiratory symptoms of CWA are plausible contributor to poor general health and quality of life among survivors. We conclude that multidisciplinary interventions are needed to tackle the biopsychosocial complications in survivors of SM exposure to minimize further health damage in the future, as well as to promote their health-related quality of life.
Sections du résumé
BACKGROUND
In 1988, Halabja came under heavy chemical warfare attack using chemicals such as sulfur mustard (SM). Thousands of survivors of SM exposure in the city today live with multiple health complaints, such as severe, long-lasting respiratory symptoms; but their perceptions of health have never been adequately researched. We aimed to explore current major health concern topics in civilian survivors with long-term respiratory symptoms.
METHOD
Sixteen subjects (f:m10:6, mean age 45.5 years (range 34-67)) were interviewed. Study participants were recruited in 2016 via a purposive sampling strategy among civilian survivors of chemical warfare in the city of Halabja in Kurdistan-Iraq. A qualitative research design was applied including semi-structured, face-to-face interviews. Data was analyzed using systematic text condensation.
RESULTS
The analysis yielded fourteen themes related to: (1) General health: all participants described a deterioration in physical and psychological health, following the SM exposure, foremost involving respiratory symptoms, fatigue, sleeping disorders, ocular problems, depressive symptoms, and anxiety; (2) Quality of life: most notably, they reported a limited family life, limited social relations, lack of work ability, and concern about their financial situation. Moreover, many lived in constant fear of a renewed attack; (3) access to health care services: all participants reported that they had no, or only poor, access to health care services and limited access to specialist care, and all reported lack of financial resources to obtain treatment.
CONCLUSIONS
The post-exposure somatic and psychosocial effects such as respiratory symptoms of CWA are plausible contributor to poor general health and quality of life among survivors. We conclude that multidisciplinary interventions are needed to tackle the biopsychosocial complications in survivors of SM exposure to minimize further health damage in the future, as well as to promote their health-related quality of life.
Identifiants
pubmed: 31226143
doi: 10.1371/journal.pone.0218648
pii: PONE-D-18-15723
pmc: PMC6588230
doi:
Substances chimiques
Chemical Warfare Agents
0
Mustard Gas
T8KEC9FH9P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0218648Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2016 Apr 19;11(4):e0152618
pubmed: 27092775
Clin Cornerstone. 2000;2(5):28-38
pubmed: 10875044
JAMA. 2006 Aug 2;296(5):560-6
pubmed: 16882962
JAMA. 1990 Feb 23;263(8):1065-6
pubmed: 2299775
BMJ. 2007 Dec 22;335(7633):1313-5
pubmed: 18156245
J Clin Nurs. 2016 Nov;25(21-22):3363-3372
pubmed: 27378192
Int J Geriatr Psychiatry. 2010 Dec;25(12):1209-21
pubmed: 20033905
Thorax. 1996 Jan;51(1):44-7
pubmed: 8658368
Ann Am Thorac Soc. 2017 Jun;14(6):1060-1072
pubmed: 28418689
J Clin Sleep Med. 2014 Nov 15;10(11):1223-30
pubmed: 25325598
Toxicology. 2009 Sep 1;263(1):9-11
pubmed: 19486919
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
BMJ. 2011 Jul 26;343:d4163
pubmed: 21791490
Patient Prefer Adherence. 2010 Dec 21;5:1-5
pubmed: 21311696
Inhal Toxicol. 2016 Jul;28(8):343-8
pubmed: 27109836
Tanaffos. 2017;16(2):115-126
pubmed: 29308076
Inhal Toxicol. 2005 Oct;17(11):587-92
pubmed: 16033754
Asia Pac Psychiatry. 2017 Jun;9(2):
pubmed: 27494204
J Rehabil Med. 2008 Jul;40(7):518-23
pubmed: 18758667
Health Qual Life Outcomes. 2009 Jan 19;7:2
pubmed: 19152700
J Nerv Ment Dis. 2008 Oct;196(10):772-5
pubmed: 18852622
Ann N Y Acad Sci. 2016 Aug;1378(1):87-95
pubmed: 27384912
Am J Emerg Med. 2014 Feb;32(2):186
pubmed: 24332250
Psychosom Med. 2003 Nov-Dec;65(6):963-70
pubmed: 14645773
Inhal Toxicol. 2010 Aug;22(9):719-24
pubmed: 20560732
Prev Chronic Dis. 2013 Nov 27;10:E199
pubmed: 24286273
Int J Chron Obstruct Pulmon Dis. 2014 Dec 04;10:1321-9
pubmed: 25587219
Nature. 1993 May 6;363(6424):3
pubmed: 8479533
Pathol Res Pract. 2006;202(10):739-44
pubmed: 16887283
Eur Child Adolesc Psychiatry. 2000 Dec;9(4):235-43
pubmed: 11202098
Palliat Support Care. 2014 Dec;12(6):465-72
pubmed: 23916195
Asian Pac J Cancer Prev. 2015;16(17):7567-73
pubmed: 26625763
Basic Clin Pharmacol Toxicol. 2006 Oct;99(4):273-82
pubmed: 17040211
Scand J Public Health. 2012 Dec;40(8):795-805
pubmed: 23221918
Toxicol Lett. 2019 Mar 15;303:9-15
pubmed: 30572106
Med J Aust. 2017 Apr 3;206(6):251-257
pubmed: 28359007
Hum Exp Toxicol. 2018 Aug;37(8):836-847
pubmed: 29069930
PLoS One. 2015 Jul 31;10(7):e0131937
pubmed: 26230265